Unknown

Dataset Information

0

Impact of frequent cerebrospinal fluid sampling on A? levels: systematic approach to elucidate influencing factors.


ABSTRACT: Cerebrospinal fluid (CSF) amyloid-beta (A?) peptides are predictive biomarkers for Alzheimer's disease and are proposed as pharmacodynamic markers for amyloid-lowering therapies. However, frequent sampling results in fluctuating CSF A? levels that have a tendency to increase compared with baseline. The impact of sampling frequency, volume, catheterization procedure, and ibuprofen pretreatment on CSF A? levels using continuous sampling over 36 h was assessed.In this open-label biomarker study, healthy participants (n?=?18; either sex, age 55-85 years) were randomized into one of three cohorts (n?=?6/cohort; high-frequency sampling). In all cohorts except cohort 2 (sampling started 6 h post catheterization), sampling through lumbar catheterization started immediately post catheterization. Cohort 3 received ibuprofen (800 mg) before catheterization. Following interim data review, an additional cohort 4 (n?=?6) with an optimized sampling scheme (low-frequency and lower volume) was included. CSF A?(1-37), A?(1-38), A?(1-40), and A?(1-42) levels were analyzed.Increases and fluctuations in mean CSF A? levels occurred in cohorts 1-3 at times of high-frequency sampling. Some outliers were observed (cohorts 2 and 3) with an extreme pronunciation of this effect. Cohort 4 demonstrated minimal fluctuation of CSF A? both on a group and an individual level. Intersubject variability in CSF A? profiles over time was observed in all cohorts.CSF A? level fluctuation upon catheterization primarily depends on the sampling frequency and volume, but not on the catheterization procedure or inflammatory reaction. An optimized low-frequency sampling protocol minimizes or eliminates fluctuation of CSF A? levels, which will improve the capability of accurately measuring the pharmacodynamic read-out for amyloid-lowering therapies.ClinicalTrials.gov NCT01436188 . Registered 15 September 2011.

SUBMITTER: Van Broeck B 

PROVIDER: S-EPMC4875639 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors.

Van Broeck Bianca B   Timmers Maarten M   Ramael Steven S   Bogert Jennifer J   Shaw Leslie M LM   Mercken Marc M   Slemmon John J   Van Nueten Luc L   Engelborghs Sebastiaan S   Streffer Johannes Rolf JR  

Alzheimer's research & therapy 20160519 1


<h4>Background</h4>Cerebrospinal fluid (CSF) amyloid-beta (Aβ) peptides are predictive biomarkers for Alzheimer's disease and are proposed as pharmacodynamic markers for amyloid-lowering therapies. However, frequent sampling results in fluctuating CSF Aβ levels that have a tendency to increase compared with baseline. The impact of sampling frequency, volume, catheterization procedure, and ibuprofen pretreatment on CSF Aβ levels using continuous sampling over 36 h was assessed.<h4>Methods</h4>In  ...[more]

Similar Datasets

| S-EPMC5769499 | biostudies-literature
| S-EPMC8583948 | biostudies-literature
| S-EPMC3270010 | biostudies-literature
| PRJNA856347 | ENA
| S-EPMC5948839 | biostudies-literature
| S-EPMC6706129 | biostudies-literature
| S-EPMC8271127 | biostudies-literature
| S-EPMC5838118 | biostudies-literature
| S-EPMC7278667 | biostudies-literature
| S-EPMC7297729 | biostudies-literature